Cargando…

Chromothripsis in Treatment Resistance in Multiple Myeloma

Multiple myeloma (MM) is a malignant disease caused by an abnormal proliferation of plasma cells, of which the prognostic factors include chromosomal abnormality, β-2 microglobulin, and albumin. Recently, the term chromothripsis has emerged, which is the massive but highly localized chromosomal rear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyoung Joo, Lee, Ki Hong, Yoon, Kyong-Ah, Sohn, Ji Yeon, Lee, Eunyoung, Lee, Hyewon, Eom, Hyeon-Seok, Kong, Sun-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korea Genome Organization 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637343/ https://www.ncbi.nlm.nih.gov/pubmed/29020724 http://dx.doi.org/10.5808/GI.2017.15.3.87

Ejemplares similares

Expression of Myeloid Antigen in Neoplastic Plasma Cells Is Related to Adverse Prognosis in Patients with Multiple Myeloma
por: Shim, Hyoeun, et al.
Publicado: (2014)

Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma
por: Lee, Nuri, et al.
Publicado: (2015)

Elevated Red Blood Cell Distribution Width as a Simple Prognostic Factor in Patients with Symptomatic Multiple Myeloma
por: Lee, Hyewon, et al.
Publicado: (2014)

Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
por: Kim, Seok Jin, et al.
Publicado: (2016)

Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse
por: Smetana, Jan, et al.
Publicado: (2018)

Chromothripsis detection with multiple myeloma patients based on deep graph learning
por: Yu, Jixiang, et al.
Publicado: (2023)

Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection
por: Lee, Se-Na, et al.
Publicado: (2017)

The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
por: Kim, Cheolsu, et al.
Publicado: (2015)

Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms
por: Lee, Eunyoung, et al.
Publicado: (2018)

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
por: Maclachlan, Kylee H., et al.
Publicado: (2021)

Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Jongheon, et al.
Publicado: (2021)

A case of synchronous multiple myeloma and chronic myeloid leukemia
por: Lee, Ji-Young, et al.
Publicado: (2017)

Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow Biopsies
por: Chung, Yousun, et al.
Publicado: (2020)

Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012
por: Park, Eun-Hye, et al.
Publicado: (2015)

Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study
por: Jung, Jongheon, et al.
Publicado: (2023)

The elusive evidence for chromothripsis
por: Kinsella, Marcus, et al.
Publicado: (2014)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)
por: Lee, Ho Sup, et al.
Publicado: (2020)

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea
por: Kim, Hyo Jung, et al.
Publicado: (2015)

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
por: Song, Ga-Young, et al.
Publicado: (2022)

Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOP
por: Kim, Min Kyeong, et al.
Publicado: (2016)

Nationwide Statistical Analysis of Lymphoid Malignancies in Korea
por: Lee, Hyewon, et al.
Publicado: (2018)

Early Response to Bortezomib Combined Chemotherapy Can Help Predict Survival in Patients with Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation
por: Lee, Ho Sup, et al.
Publicado: (2013)

Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study
por: Kwon, Jihyun, et al.
Publicado: (2016)

Chromothripsis and DNA Repair Disorders
por: Nazaryan-Petersen, Lusine, et al.
Publicado: (2020)

Chromothripsis—Explosion in Genetic Science
por: Shorokhova, Mariia, et al.
Publicado: (2021)

Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma
por: Jung, Jongheon, et al.
Publicado: (2017)

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma
por: Jung, Jongheon, et al.
Publicado: (2021)

Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
por: Lee, Sung-Eun, et al.
Publicado: (2018)

CHROMOTHRIPSIS FROM DNA DAMAGE IN MICRONUCLEI
por: Zhang, Cheng-Zhong, et al.
Publicado: (2015)

Chromosomal rearrangements in uveal melanoma: Chromothripsis
por: van Poppelen, Natasha M., et al.
Publicado: (2018)

On the Complexity of Mechanisms and Consequences of Chromothripsis: An Update
por: Koltsova, Alla S., et al.
Publicado: (2019)

Insight into the Molecular Basis Underlying Chromothripsis
por: Ostapińska, Katarzyna, et al.
Publicado: (2022)

Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008
por: Park, Hyeon Jin, et al.
Publicado: (2012)

Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma
por: Lee, Eun Jeong, et al.
Publicado: (2016)

The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma
por: Min, Chang-Ki, et al.
Publicado: (2013)

A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma
por: Kim, Youngwoon, et al.
Publicado: (2012)

Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
por: Batsukh, Khishigjargal, et al.
Publicado: (2017)

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
por: Lee, Sung-Eun, et al.
Publicado: (2019)

ShatterProof: operational detection and quantification of chromothripsis
por: Govind, Shaylan K, et al.
Publicado: (2014)

Copy number variations and constitutional chromothripsis (Review)
por: Brás, Aldina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g48np25bqada1bhhrpfvguv1os